eHealth Initiative's Connecting Communities for Drug Safety Collaboration
The non-profit eHealth Initiative Foundation (eHI) announced today the formation of an innovative research program designed to improve drug safety for patients. The eHI Connecting Communities for Drug Safety Collaboration is a public-private sector effort designed to test new approaches and develop replicable tools for assessing both the risks and the benefits of new drug treatments through the use of health information technology.
Read more ...
Common Application for Orphan Designation for Medicines
The European Commission, the European Medicines Agency (EMEA) and the United States (US) Food and Drug Administration (FDA) have adopted a common application form for sponsors seeking orphan designation of medicines in the European Union (EU) and US. This initiative is aimed at simplifying the process of obtaining orphan status for medicines intended for rare diseases in both jurisdictions.
Read more ...
French scientists identify possible new target for obesity treatment
French researchers have identified a protein that influences the body's sensitivity to leptin, the hormone that controls our body weight by letting us know when we have had enough to eat. The work, which is published online by the journal the Proceedings of the National Academy of Sciences (PNAS), could lead to the development of new treatments for obesity.
Read more ...
Results of a Survey of Parents' Perceptions of the Duration of their Child's ADHD Medication
Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, announced results of a national survey where 60 percent of 121 mothers reported their 6 to 12 year old child's once-daily Attention Deficit Hyperactivity Disorder (ADHD) medication stopped working before 6 p.m. The survey findings report the perceptions of 500 parents of children with ADHD regarding the duration of effectiveness of their child's once-daily stimulant or non-stimulant ADHD medication and were presented yesterday at the 2007 Children and Adults with Attention-Deficit Hyperactivity Disorder (CHADD) Annual Conference.
Read more ...
Web Site Helps Alleviate Stress Associated with Caring for Children with Diabetes During the Holiday
Holidays often induce stress, but caring for children with diabetes this time of year can mean an additional layer of pressure. Parents and caregivers can visit a webiste to participate in live Web chats with diabetes specialists for expert advice on how to best manage a child's diabetes during the holidays, find social support and receive a free download of the 'Diabetes Fit Food' booklet for tips on healthy eating.
Read more ...
Computational modelling allows insights into cell membrane fusion
Researchers from France, the UK and Austria have modelled the SNARE protein complex that acts as a catalyst in the fusion of two membranes, using the processing power of the Distributed European Infrastructure for Supercomputing Applications (DEISA). They hope to open up new opportunities for pharmaceutical development.
Read more ...
More than 25 Years of Archived Biomedical and Pharmacological Records Acessible in Electronic Format
Thomson Scientific, part of The Thomson Corporation (NYSE: TOC; TSX: TOC) and leading provider of information solutions to the worldwide research and business communities, today announced that it has added EMBASE® Classic to the Dialog® (File 772) and DataStar® (EM73, EMXX) platforms, providing access to more than 25 years of archived life sciences data available for the first time in electronic format.
Read more ...
The European Commission, the European Medicines Agency (EMEA) and the United States (US) Food and Drug Administration (FDA) have adopted a common application form for sponsors seeking orphan designation of medicines in the European Union (EU) and US. This initiative is aimed at simplifying the process of obtaining orphan status for medicines intended for rare diseases in both jurisdictions. 
Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, announced results of a national survey where 60 percent of 121 mothers reported their 6 to 12 year old child's once-daily Attention Deficit Hyperactivity Disorder (ADHD) medication stopped working before 6 p.m. The survey findings report the perceptions of 500 parents of children with ADHD regarding the duration of effectiveness of their child's once-daily stimulant or non-stimulant ADHD medication and were presented yesterday at the 2007 Children and Adults with Attention-Deficit Hyperactivity Disorder (CHADD) Annual Conference. 
Holidays often induce stress, but caring for children with diabetes this time of year can mean an additional layer of pressure. Parents and caregivers can visit a webiste to participate in live Web chats with diabetes specialists for expert advice on how to best manage a child's diabetes during the holidays, find social support and receive a free download of the 'Diabetes Fit Food' booklet for tips on healthy eating. 
Thomson Scientific, part of The Thomson Corporation (NYSE: TOC; TSX: TOC) and leading provider of information solutions to the worldwide research and business communities, today announced that it has added EMBASE® Classic to the Dialog® (File 772) and DataStar® (EM73, EMXX) platforms, providing access to more than 25 years of archived life sciences data available for the first time in electronic format.